Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Belite Bio to Participate in Three Upcoming Investor Conferences
-
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
-
Fusion Fuel Green PLC to Release a Mid-Year Investor Update on September 17, 2025
-
JLab Reveals Its 2025-2026 NIL Playmaker Roster Featuring Top College Football Athletes
-
BIGC Raises $14M to Fuel Global Expansion of Its All-in-One Digital Venue Platform
-
Alignment Healthcare to Present at Morgan Stanley 23rd Annual Global Healthcare Conference and Baird 2025 Global Healthcare Conference
-
Anteriad Advances Global Growth Strategy with Senior Executive Promotions in APAC
-
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
-
U.S. Army Taps LiquidPiston to Build Ultra-Compact Mobile Command Post Auxiliary Power Unit
-
Stanley Steemer Appoints Andrew Schneider as Head of Marketing and Selects Havas Chicago as Creative Agency
-
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
-
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
-
Septerna to Participate in Upcoming Investor Conferences
-
MIMEDX to Participate in Upcoming Investor Conferences
-
Discuss Introduces “Vibe Coding” and Hybrid AI + Human Market Insight Platform
-
T-RIZE and Republic Launch 'Vision 60' to Expand Institutional Access to Tokenized Real Estate
-
BriteCore to Host Webinar on Reducing Insurance Payment Processing Costs by Two-Thirds Through PAS and Payments Integration
-
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices
-
Recursion to Participate in Upcoming Investor Conferences
-
Global Virus Network Announces 2025 Rising Star Mentorship Program Awardees
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
-
Annexon Biosciences to Participate in Upcoming September Investor Conferences
-
Maxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director
-
Transaction in Own Shares
-
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Consolidated Lithium Metals Inc. Signs Letter of Intent with SOQUEM to Earn up to 80% Interest in the Kwyjibo Rare Earth Project, Québec
-
Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results
-
Aer Therapeutics to Participate at Cantor Global Healthcare Conference
-
NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 17th, 2025
-
GAMCO Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.05 Per Share
-
ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
-
Farmers of Salem Supports Local Students with Back-to-School Donations
-
Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update
-
NANO Nuclear Expands Presence in Argentina By Signing Memorandum of Understanding with Dioxitek S.A., Argentina’s Only Uranium Feedstock Manufacturer for Nuclear Fuel Fabrication
-
Valour Launches Eight New ETPs on Spotlight Stock Market, Including Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena (ENA), and Celestia (TIA)
-
GAMCO Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.05 Per Share
-
Quipt Home Medical Confirms Receipt of Forager’s Repetitive Undervalued Offer; Board Denounces Inferior Terms and Self-Serving Tactics
-
Donald Tremblay Joins Telesat as Chief Financial Officer
-
Dragonfly Energy Partners with Awaken RV to Power Next-Generation Fiberglass Travel Trailers
-
Bread Financial Announces Approval of $200 Million Share Repurchase Program
-
Rezolute to Participate in Upcoming Investor Conferences
-
Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results
-
DallasNews Rejects Revised Non-Binding Proposal from Affiliate of Alden Global Capital
-
Bancroft Fund Ltd. Declares Distribution of $0.32 per Share
-
Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.16 per Share
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Results
-
BridgeBio to Participate in September Investor Conferences

